Procyon Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,119
Closed -$372K 652
2026
Q1
$372K Buy
7,119
+2,567
+56% +$154K 0.02% 407
2025
Q4
$268K Sell
4,552
-2,947
-39% -$179K 0.01% 464
2025
Q3
$417K Buy
+7,499
New +$402K 0.02% 343
2025
Q1
Sell
-3,200
Closed -$230K 620
2024
Q4
$230K Sell
3,200
-57
-2% -$4.19K 0.01% 500
2024
Q3
$260K Sell
3,257
-14
-0.4% -$1.05K 0.02% 468
2024
Q2
$234K Buy
3,271
+47
+1% +$3.46K 0.02% 465
2024
Q1
$227K Sell
3,224
-226
-7% -$16.2K 0.02% 471
2023
Q4
$266K Buy
3,450
+26
+0.8% +$1.71K 0.02% 438
2023
Q3
$233K Buy
3,424
+537
+19% +$42.4K 0.02% 433
2023
Q2
$236K Buy
+2,887
New +$232K 0.03% 401
2023
Q1
Sell
-2,664
Closed -$221K 396
2022
Q4
$221K Buy
+2,664
New +$212K 0.04% 338
2022
Q3
Sell
-2,664
Closed -$231K 333
2022
Q2
$231K Hold
2,664
0.05% 284
2022
Q1
$288K Hold
2,664
0.06% 270
2021
Q4
$345K Buy
2,664
+320
+14% +$39.2K 0.07% 234
2021
Q3
$284K Hold
2,344
0.07% 249
2021
Q2
$264K Hold
2,344
0.07% 243
2021
Q1
$224K Sell
2,344
-1,784
-43% -$163K 0.1% 226
2020
Q4
$328K Hold
4,128
0.16% 149
2020
Q3
$256K Hold
4,128
0.14% 163
2020
Q2
$273K Sell
4,128
-808
-16% -$48.4K 0.15% 137
2020
Q1
$234K Sell
4,936
-16
-0.3% -$800 0.16% 129
2019
Q4
$272K Buy
+4,952
New +$260K 0.17% 126

Other funds holding TECH

Procyon Advisors's TECH Position: Q2 2026 in Review

Procyon Advisors sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 7,119 shares — an estimated $372K sold.

Procyon Advisors first reported a position in TECH in Q4 2019 and held it in 22 quarters. The position peaked at $417K in Q3 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Procyon Advisors reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Procyon Advisors sold 7,119 Bio-Techne shares in Q2 2026, an estimated $372K.
  • Procyon Advisors first reported a position in Bio-Techne in Q4 2019 and held it in 22 quarters.
  • Procyon Advisors's Bio-Techne position peaked at $417K in Q3 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.